These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 11968343

  • 41. Up to date treatment of hepatitis C in adults.
    Schalm SW, Brouwer JT.
    Acta Gastroenterol Belg; 1998; 61(4):397-9. PubMed ID: 9923088
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Effectiveness of conventional interferon and ribavirin combination therapy in chronic Hepatitis C patients in Pakistan.
    Bukhsh A, Goh BH, Lee LH, Khan TM.
    J Infect Public Health; 2017; 10(5):692-693. PubMed ID: 28209323
    [No Abstract] [Full Text] [Related]

  • 44. Telaprevir use in a chronic hepatitis C patient with hemophilia.
    Guner R, Tufan ZK.
    Eur J Gastroenterol Hepatol; 2014 Feb; 26(2):248. PubMed ID: 24366457
    [No Abstract] [Full Text] [Related]

  • 45. [Naturopathy consultation. Soon all patients will be curable. Decisive breakthrough in therapy of hepatitis C ].
    Einecke D.
    MMW Fortschr Med; 2014 Feb 20; 156(3):26-7. PubMed ID: 24938054
    [No Abstract] [Full Text] [Related]

  • 46. Combination treatment for hepatitis C is not being given.
    Foster GR, Chapman R.
    BMJ; 2000 Oct 07; 321(7265):899. PubMed ID: 11021891
    [No Abstract] [Full Text] [Related]

  • 47. [Current treatment of chronic hepatitis B].
    Rodríguez M, Pérez R.
    Gastroenterol Hepatol; 2001 Feb 07; 24 Suppl 1():51-7. PubMed ID: 11279894
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. [Interferon treatment of chronic hepatitis C viral hepatitis patients with normal transaminases].
    Remy AJ, Blanc P.
    Gastroenterol Clin Biol; 1998 Feb 07; 22(8-9):748-9. PubMed ID: 9823572
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Retreatment of interferon relapse patients with chronic hepatitis C.
    Buti M, Esteban R.
    J Hepatol; 1999 Feb 07; 31 Suppl 1():174-7. PubMed ID: 10622582
    [No Abstract] [Full Text] [Related]

  • 52. [Should we treat cirrhosis in hepatitis C carriers with antiviral agents?].
    Brenard R, Closon ML, Fevery J, Hautekeete M.
    Rev Med Brux; 1999 Feb 07; 20(1):A50. PubMed ID: 10091538
    [No Abstract] [Full Text] [Related]

  • 53. Ribavirin and use of clotting factors in patients with hemophilia and chronic hepatitis C.
    Honda T, Toyoda H, Hayashi K, Katano Y, Yano M, Nakano I, Yoshioka K, Goto H, Yamamoto K, Takamatsu J.
    JAMA; 2005 Mar 09; 293(10):1190-2. PubMed ID: 15755940
    [No Abstract] [Full Text] [Related]

  • 54. Nonresponse to interferon in chronic hepatitis C: re-treatment redux.
    Koff R.
    JAMA; 2001 Jan 10; 285(2):212-4. PubMed ID: 11176816
    [No Abstract] [Full Text] [Related]

  • 55. [Predicting factors in the efficacy of interferon treatment in chronic hepatitis C].
    Rodríguez Agulló JL.
    An Med Interna; 2001 Jul 10; 18(7):349-50. PubMed ID: 11534417
    [No Abstract] [Full Text] [Related]

  • 56. [Selection of therapy in patients with chronic hepatitis C showing features like autoimmune hepatitis].
    Kakumu S.
    Nihon Rinsho; 2004 Jul 10; 62 Suppl 7(Pt 1):663-6. PubMed ID: 15359881
    [No Abstract] [Full Text] [Related]

  • 57. [Treatment of chronic hepatitis C relapse].
    Olivé G, Buti M, Esteban-Mur R, Guardia J.
    Gastroenterol Hepatol; 2000 Feb 10; 23 Suppl 1():47-50. PubMed ID: 11968344
    [No Abstract] [Full Text] [Related]

  • 58. Mechanisms of action of interferon and ribavirin in chronic hepatitis C: Summary of a workshop.
    Chung RT, Gale M, Polyak SJ, Lemon SM, Liang TJ, Hoofnagle JH.
    Hepatology; 2008 Jan 10; 47(1):306-20. PubMed ID: 18161743
    [No Abstract] [Full Text] [Related]

  • 59. Oral thymic extract to treat hepatitis C.
    Frossard JL.
    Ann Intern Med; 1999 Aug 17; 131(4):312. PubMed ID: 10454958
    [No Abstract] [Full Text] [Related]

  • 60. Should routine screening for coeliac disease be considered before starting interferon/ribavirin treatment in patients affected by chronic hepatitis C?
    Casella G, Bardella MT, Perego D, Baldini V.
    Eur J Gastroenterol Hepatol; 2004 Apr 17; 16(4):429. PubMed ID: 15028979
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.